0

Nitazoxanide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP55981094-A
CAS55981-09-4
Structure
MDL NumberMFCD00416599
Molecular Weight307.28
InChI KeyYQNQNVDNTFHQSW-UHFFFAOYSA-N
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size200MG
1

Antiviral Treatment of COVID-19

Serap Şimşek Yavuz, Serhat Ünal

Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619.

PMID: 32293834

1

Nitazoxanide

PMID: 29999627

1

Nitazoxanide, a New Drug Candidate for the Treatment of Middle East Respiratory Syndrome Coronavirus

Jean-François Rossignol

J Infect Public Health. May-Jun 2016;9(3):227-30.

PMID: 27095301

1

Nitazoxanide: A First-In-Class Broad-Spectrum Antiviral Agent

Jean-François Rossignol

Antiviral Res. 2014 Oct;110:94-103.

PMID: 25108173

1

The Role of Adjuvant Immunomodulatory Agents for Treatment of Severe Influenza

David S Hui, Nelson Lee, Paul K Chan, John H Beigel

Antiviral Res. 2018 Feb;150:202-216.

PMID: 29325970

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode